Snails—Yes, Snails—Are Helping Unlock Faster Insulins
Scientists have uncovered a potential breakthrough in developing a faster acting insulin in an unusual place: snails. Now, Breakthrough T1D-funded researchers are using the molecular features of the snail insulin to create ultra-rapid insulins for people with type 1 diabetes (T1D) and have published their findings in . As discussed in last year’s blog, certain […]
Medtronic Panel Discusses Supporting T1D Community During COVID-19
During a recent Breakthrough T1D Facebook Live event, a panel of leaders discussed Medtronic’s efforts to support the T1D community during the pandemic.
TTP399: A Potential First-in-Class Adjunct Therapy in Type 1 Diabetes
Nearly 80 percent of people with type 1 diabetes (T1D) fail to meet HbA1c goals defined by the American Diabetes Association. Despite more widely adopted diabetes technology and an increase in use, there is no improvement in clinical outcomes. This tells us that the current use of insulin alone is not enough, but vTv Therapeutics […]
Breakthrough T1D and Gore Invest in Development of Implantable Insulin Delivery System
PhysioLogic Devices, a Breakthrough T1D-funded company that is dedicated to transforming the treatment of type 1 diabetes (T1D), wants to develop the ThinPump™—a fully implantable automated insulin delivery system—in the next four years. We think it’s not only possible, but doable. PhysioLogic has two things going for it: Gore is well known for developing GORE-TEX […]
